For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
The closing price of Akari Therapeutics Plc ADR (NASDAQ: AKTX) was $0.28 for the day, down -1.74% from the previous closing price of $0.29. In other words, the price has decreased by -$1.74 from its previous closing price. On the day, 0.51 million shares were traded. AKTX stock price reached its highest trading level at $0.304 during the session, while it also had its lowest trading level at $0.275.
Ratios:
Our analysis of AKTX’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 0.19 and its Current Ratio is at 0.19. In the meantime, Its Debt-to-Equity ratio is 0.09 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In the most recent recommendation for this company, Ladenburg Thalmann on January 05, 2026, initiated with a Buy rating and assigned the stock a target price of $1.
On July 18, 2025, Maxim Group started tracking the stock assigning a Buy rating and target price of $5.
B. Riley FBR Upgraded its Neutral to Buy on January 04, 2019, whereas the target price for the stock was revised from $2.50 to $3.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Aug 21 ’25 when Gaslightwala Abizer bought 10,000 shares for $0.94 per share. The transaction valued at 9,400 led to the insider holds 287,574 shares of the business.
Gaslightwala Abizer bought 8,000 shares of AKTX for $7,440 on Aug 22 ’25. The CEO now owns 295,574 shares after completing the transaction at $0.93 per share. On Aug 25 ’25, another insider, Gaslightwala Abizer, who serves as the CEO of the company, bought 3,000 shares for $0.90 each. As a result, the insider paid 2,700 and bolstered with 298,574 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AKTX now has a Market Capitalization of 10092901 and an Enterprise Value of 20185532416.
Stock Price History:
The Beta on a monthly basis for AKTX is 0.36, which has changed by -0.763786 over the last 52 weeks, in comparison to a change of 0.1877265 over the same period for the S&P500. Over the past 52 weeks, AKTX has reached a high of $1.73, while it has fallen to a 52-week low of $0.22. The 50-Day Moving Average of the stock is -35.51%, while the 200-Day Moving Average is calculated to be -69.57%.
Shares Statistics:
AKTX traded an average of 1.07M shares per day over the past three months and 807100 shares per day over the past ten days. A total of 32.61M shares are outstanding, with a floating share count of 32.48M. Insiders hold about 0.40% of the company’s shares, while institutions hold 3.79% stake in the company. Shares short for AKTX as of 1765756800 were 519225 with a Short Ratio of 0.48, compared to 1763078400 on 119117. Therefore, it implies a Short% of Shares Outstanding of 519225 and a Short% of Float of 2.18.
